title: Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.
abstract: A subset of HIV-1-infected patients known as elite controllers or suppressors (ES) control the virus naturally. We have previously demonstrated sequence discordance between proviral and plasma gag clones in ES, much of which can be attributed to selective pressure from the host (J. R. Bailey, T. M. Williams, R. F. Siliciano, and J. N. Blankson, J. Exp. Med. 203:1357-1369, 2006). However, it is not clear whether ongoing viral replication continues in ES once the control of viremia has been established or whether selective pressure impacts this evolution. The cytotoxic T-lymphocyte (CTL) response in ES often targets Gag and frequently is superior to that of HIV-1 progressors, partially due to the HLA class I alleles B*57/5801 and B*27, which are overrepresented in ES. We therefore examined longitudinal plasma and proviral gag sequences from HLA-B*57/5801 and -B*27 ES. Despite the highly conserved nature of gag, we observed clear evidence of evolution in the plasma virus, largely due to synonymous substitutions. In contrast, evolution was rare in proviral clones, suggesting that ongoing replication in ES does not permit the significant reseeding of the latent reservoir. Interestingly, there was little continual evolution in CTL epitopes, and we detected de novo CTL responses to autologous viral mutants. Thus, some ES control viremia despite ongoing replication and evolution.
authors.affiliation: Broadway Research Bldg., Rm 880, Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD 21205, USA.
authors.forename: Karen A
authors.initials: KA
authors.lastname: O'Connell
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Brennan
authors.forename: Justin R
authors.initials: JR
authors.lastname: Bailey
authors.forename: Stuart C
authors.initials: SC
authors.lastname: Ray
authors.forename: Robert F
authors.initials: RF
authors.lastname: Siliciano
authors.forename: Joel N
authors.initials: JN
authors.lastname: Blankson
mesh_terms: D000595:Amino Acid Sequence; D000939:Epitopes; D019143:Evolution, Molecular; D015658:HIV Infections / Q000276:immunology* / Q000503:physiopathology / Q000821:virology*; D020276:HIV Long-Term Survivors; D015497:HIV-1 / Q000145:classification / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D015235:HLA-B Antigens / Q000235:genetics / Q000276:immunology; D006801:Humans; D008969:Molecular Sequence Data; D010802:Phylogeny; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D019562:Viral Load; D014766:Viremia / Q000276:immunology / Q000821:virology; D014779:Virus Replication
chemical_list: D000939:Epitopes; D015235:HLA-B Antigens; C484830:HLA-B*57:01 antigen; C500126:HLA-B*58:01 antigen
references.citation: AIDS. 2005 Nov 18;19(17):2001-7
references.pmid: 16260907
references.citation: Immunity. 2008 Dec 19;29(6):1009-21
references.pmid: 19062316
references.citation: J Infect Dis. 2008 Feb 15;197(4):563-71
references.pmid: 18275276
references.citation: J Virol. 2007 Nov;81(22):12608-18
references.pmid: 17728232
references.citation: Nat Med. 2004 Mar;10(3):282-9
references.pmid: 14770175
references.citation: Nat Immunol. 2002 Nov;3(11):1061-8
references.pmid: 12368910
references.citation: J Immunol. 2009 Jun 15;182(12):7828-37
references.pmid: 19494307
references.citation: Nat Rev Immunol. 2004 Aug;4(8):630-40
references.pmid: 15286729
references.citation: Nat Med. 2006 Dec;12(12):1365-71
references.pmid: 17115046
references.citation: J Virol. 2008 Jun;82(11):5594-605
references.pmid: 18385228
references.citation: J Exp Med. 2006 May 15;203(5):1357-69
references.pmid: 16682496
references.citation: J Virol. 2008 Sep;82(18):9216-27
references.pmid: 18614631
references.citation: J Infect Dis. 2008 Jan 1;197(1):126-33
references.pmid: 18171295
references.citation: Clin Infect Dis. 2008 Apr 15;46(8):e78-82
references.pmid: 18444844
references.citation: PLoS Genet. 2009 Mar;5(3):e1000431
references.pmid: 19300501
references.citation: J Virol. 2008 Aug;82(15):7395-410
references.pmid: 18495769
references.citation: J Virol. 2009 Sep;83(17):8470-81
references.pmid: 19535437
references.citation: J Virol. 2006 Jul;80(13):6441-57
references.pmid: 16775332
references.citation: Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2709-14
references.pmid: 10694578
references.citation: Trends Pharmacol Sci. 2009 Dec;30(12):631-7
references.pmid: 19837464
references.citation: J Infect Dis. 2009 Sep 15;200(6):984-90
references.pmid: 19656066
references.citation: J Virol. 2009 Jan;83(1):329-35
references.pmid: 18945778
references.citation: AIDS. 2009 Jun 1;23(9):1163-9
references.pmid: 19444075
references.citation: J Exp Med. 2009 Jun 8;206(6):1253-72
references.pmid: 19487423
references.citation: Mol Biol Evol. 1986 Sep;3(5):418-26
references.pmid: 3444411
references.citation: Clin Infect Dis. 2005 Oct 1;41(7):1053-6
references.pmid: 16142675
references.citation: J Infect Dis. 2009 Dec 15;200(12):1820-4
references.pmid: 19909081
references.citation: JAMA. 2005 Feb 16;293(7):817-29
references.pmid: 15713771
references.citation: Mol Biol Evol. 2007 Aug;24(8):1596-9
references.pmid: 17488738
references.citation: Clin Infect Dis. 2008 Jul 1;47(1):102-4
references.pmid: 18494606
references.citation: J Virol. 1999 Dec;73(12):10489-502
references.pmid: 10559367
references.citation: J Exp Med. 2007 Oct 1;204(10):2473-85
references.pmid: 17893201
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6776-81
references.pmid: 17428922
references.citation: Blood. 2006 Jun 15;107(12):4781-9
references.pmid: 16467198
references.citation: Virology. 2003 Jul 20;312(1):135-50
references.pmid: 12890627
references.citation: J Virol. 2006 Apr;80(7):3617-23
references.pmid: 16537629
references.citation: J Virol. 2003 Jun;77(12):6889-98
references.pmid: 12768008
references.citation: J Virol. 2008 Jun;82(11):5398-407
references.pmid: 18353945
references.citation: AIDS. 2008 Feb 19;22(4):541-4
references.pmid: 18301071
references.citation: J Virol. 2007 Mar;81(5):2508-18
references.pmid: 17151109
references.citation: J Virol. 2009 Jan;83(1):88-97
references.pmid: 18945771
references.citation: Clin Infect Dis. 2010 Mar 15;50(6):912-9
references.pmid: 20156060
references.citation: J Virol. 2007 Aug;81(15):8346-51
references.pmid: 17507468
references.citation: J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):403-8
references.pmid: 19214118